Live feed08:35:47·753dSECFilingvia QuantisnowDay One Biopharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD DisclosureByQuantisnow·Wall Street's wire, on your screen.DAWN· Day One Biopharmaceuticals Inc.Health CareOriginal source
